Categories Covid-19 冠病19 News 新闻报道 CureVac冠病疫苗 有效性偏低 Post author By imguohao Post date June 17, 2021 No Comments on CureVac冠病疫苗 有效性偏低 数据显示,德国生物技术制药公司CureVac所研发的2019冠状病毒疾病疫苗有效性偏低。 尽管公司对拉丁美洲和欧洲4万名志愿者展开的试验所收集到的数据还没有全部被评估,但中期试验结果只显示出百分之47的有效性,这并不符合之前预期的统计成功标准。 相关数据已经提交给欧洲药品管理局。 公司将继续展开最终分析。 ← 拜登: 和习近平虽彼此了解 但称不上是老朋友 → 本地失业率有所缓和 Leave a Reply Cancel reply Enter your comment here... Fill in your details below or click an icon to log in: Email (required) (Address never made public) Name (required) Website You are commenting using your WordPress.com account. ( Log Out / Change ) You are commenting using your Twitter account. ( Log Out / Change ) You are commenting using your Facebook account. ( Log Out / Change ) Cancel Connecting to %s Notify me of new comments via email. Notify me of new posts via email. Δ